Lmcg Investments, LLC’s Abbott Laboratories Position
Does Lmcg Investments, LLC own Abbott Laboratories (ABT)? Yes — 101.4K shares worth $10M (+0.62% of its 13F portfolio) as of Q1 2026, down from 134.8K shares the prior filed quarter.
Position Value
$10M
Q1 2026
Shares
101.4K
% of Portfolio
+0.62%
Quarters Held
17
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 101.4K | $10M | +0.62% |
| Q4 2025 | 134.8K | $17M | +0.97% |
| Q3 2025 | 139.7K | $19M | +1.10% |
| Q2 2025 | 143.7K | $20M | +1.23% |
| Q1 2025 | 148.7K | $20M | +1.31% |
| Q4 2024 | 161.1K | $18M | +1.12% |
| Q3 2024 | 170.6K | $19M | +1.17% |
| Q2 2024 | 176.6K | $18M | +1.07% |
| Q1 2024 | 144.1K | $16M | +0.96% |
| Q4 2023 | 149.8K | $16M | +1.02% |
| Q3 2023 | 129.8K | $13M | +0.85% |
| Q2 2023 | 132.1K | $14M | +0.93% |
| Q1 2023 | 135.3K | $14M | +0.91% |
| Q4 2022 | 136.6K | $15M | +1.05% |
| Q3 2022 | 136.5K | $13M | +0.97% |
| Q2 2022 | 138.1K | $15M | +1.03% |
| Q1 2022 | 139.0K | $16M | +0.95% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lmcg Investments, LLC’s full portfolio or all institutional holders of ABT.